A little over a year after winning manufacturing certification for its cell therapy factory-in-a-box, South San Francisco’s Cellares has passed another major production milestone. Cellares’ automated ...

Researchers recently enhanced the titer of a cell line still in development to produce adenovirus viral vectors by 7.5-fold, and without the risk of also producing replication-competent adenoviruses ...

Solid-state battery developer QuantumScape is approaching the end of 2025 with all of its key goals achieved. The latest development is the installation of key equipment to enable higher-volume QSE-5 ...